 Crinetics Pharmaceuticals Inc NASDAQ:CRNX major shareholder Vivo Capital Viii, Llc sold 300,000 shares of the companys stock in a transaction on Friday, April 3rd. The stock was sold at an average price of 13.80, for a total value of 4,140,000.00. The sale was disclosed in a filing with the SEC, which is available at this ... 